Theravance Biopharma (NASDAQ:TBPH) Shares Gap Down to $24.67

Share on StockTwits

Theravance Biopharma Inc (NASDAQ:TBPH) shares gapped down prior to trading on Thursday . The stock had previously closed at $23.22, but opened at $24.67. Theravance Biopharma shares last traded at $25.25, with a volume of 11,718 shares changing hands.

TBPH has been the topic of a number of research reports. HC Wainwright upped their price target on shares of Theravance Biopharma from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, January 8th. BidaskClub lowered shares of Theravance Biopharma from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Robert W. Baird upgraded shares of Theravance Biopharma from an “underperform” rating to a “neutral” rating and decreased their target price for the stock from $22.00 to $18.00 in a research report on Wednesday, November 6th. Piper Jaffray Companies decreased their target price on shares of Theravance Biopharma from $55.00 to $40.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 6th. Finally, ValuEngine lowered shares of Theravance Biopharma from a “buy” rating to a “hold” rating in a research report on Wednesday, January 29th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $35.75.

The stock’s 50-day simple moving average is $26.35 and its 200-day simple moving average is $21.67. The stock has a market cap of $1.42 billion, a price-to-earnings ratio of -6.25 and a beta of 1.92.

Several large investors have recently made changes to their positions in TBPH. Nuveen Asset Management LLC acquired a new position in shares of Theravance Biopharma during the 2nd quarter worth approximately $3,610,000. NJ State Employees Deferred Compensation Plan grew its position in shares of Theravance Biopharma by 22.5% during the 3rd quarter. NJ State Employees Deferred Compensation Plan now owns 38,142 shares of the biopharmaceutical company’s stock worth $743,000 after purchasing an additional 7,000 shares in the last quarter. Quadrant Capital Group LLC acquired a new position in shares of Theravance Biopharma during the 3rd quarter worth approximately $32,000. Chicago Equity Partners LLC grew its position in shares of Theravance Biopharma by 54.5% during the 3rd quarter. Chicago Equity Partners LLC now owns 81,960 shares of the biopharmaceutical company’s stock worth $1,597,000 after purchasing an additional 28,895 shares in the last quarter. Finally, California Public Employees Retirement System grew its position in shares of Theravance Biopharma by 30.7% during the 3rd quarter. California Public Employees Retirement System now owns 81,966 shares of the biopharmaceutical company’s stock worth $1,597,000 after purchasing an additional 19,251 shares in the last quarter. Hedge funds and other institutional investors own 68.92% of the company’s stock.

About Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma, Inc, a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines. The company offers VIBATIV, a bactericidal, once-daily injectable antibiotic to treat patients with serious, life-threatening infections due to staphylococcus aureus and other gram-positive bacteria, including methicillin-resistant.

Featured Story: How is the discount rate different from the Federal Funds rate?

Receive News & Ratings for Theravance Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theravance Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

GAM Holding AG Decreases Holdings in Lear Co.
GAM Holding AG Decreases Holdings in Lear Co.
GAM Holding AG Makes New Investment in FirstEnergy Corp.
GAM Holding AG Makes New Investment in FirstEnergy Corp.
GAM Holding AG Sells 1,916 Shares of Constellation Brands, Inc.
GAM Holding AG Sells 1,916 Shares of Constellation Brands, Inc.
GAM Holding AG Reduces Stock Position in Philip Morris International Inc.
GAM Holding AG Reduces Stock Position in Philip Morris International Inc.
GAM Holding AG Makes New $332,000 Investment in Nordson Co.
GAM Holding AG Makes New $332,000 Investment in Nordson Co.
Cracker Barrel Old Country Store, Inc.  Shares Sold by GAM Holding AG
Cracker Barrel Old Country Store, Inc. Shares Sold by GAM Holding AG


 
© 2006-2020 Zolmax.